Acute Coronary Syndrome
Conditions
Keywords
Cost analysis, Safety, Length of stay, Randomized controlled trials, Early discharge
Brief summary
The investigators will make a prospective study in which they will look at the economics and security of the treatment of patients with acute coronary syndrome. The investigators want to do a randomized trial. One group will be treated as they have been treated at Ullevål University Hospital (UUS) in recent years, and the other group will be returned to their refering hospital the same day. The objective of this study will be to provide increased knowledge about whether the rapid discharge from the intervention center is associated with differences in costs or security.
Detailed description
The topic of this study is whether patients with Acute coronary syndrome (ACS)may can be transferred to their refering hospital same day that they arrived intervention hospital. This is to see if one can reduce the hospital stay and costs for the intervention center, and the total hospitalization time. and this rapid transport not give more medical complications Our 1 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day, will reduce the length of stay in intervention center without an increase for the stay at the refering hospital. Our 2 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day as the treatment is performed, have no more complications than those who stay overnight in the intervention hospital.
Interventions
The patients are discharged the same day as coronary angiography.
The patients are admitted and cared as usual in cardiology ward.
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients with acute coronary syndrome who are referred from other hospitals
Exclusion criteria
* Patients younger than 18years. * Known mental retardation, dementia or harmful use of alcohol or drugs. * Allergy or intolerance to ASA and / or clopidogrel. * Patients who have previously been involved in this study. * Acute STEMI infarction for less than 72 hours ago.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cost effectiveness. Adverse medical events | 30 days and a year's events |
Secondary
| Measure | Time frame |
|---|---|
| SF-36 | One year |
Countries
Norway